Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of pedicel glucoside in the preparation of anti-influenza virus drugs

A technology of leucoside and influenza virus, which is applied in the directions of antiviral agents, drug combinations, pharmaceutical formulations, etc., to achieve the effect of reducing lung index

Active Publication Date: 2020-02-21
SUN YAT SEN UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no research report on the anti-influenza virus effect of pedicel glucoside

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of pedicel glucoside in the preparation of anti-influenza virus drugs
  • Application of pedicel glucoside in the preparation of anti-influenza virus drugs
  • Application of pedicel glucoside in the preparation of anti-influenza virus drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Example 1 The preparation of the extract of medicinal materials

[0015] Get an appropriate amount of Bing medicinal materials, crush them, pass through a No. 1 sieve, add 8 times the amount of 70% (volume fraction) ethanol to the medicinal materials, heat and reflux for extraction twice, each time for 1 hour, filter, combine the extracts, put them in a rotary evaporator, Concentrate under reduced pressure at 80°C to a thick paste. Transfer the concentrated solution to a decompression drying oven, continue drying and crushing at 80°C, and obtain the rescued Bing medicinal material extract (detected by liquid chromatography, the mass fraction of pedicel glucoside in the extract is 200 mg / g).

Embodiment 2

[0016] Example 2 In vitro Influenza Virus Inhibition Experiment

[0017] 1. Experimental materials

[0018] 1.1 Tested drug: pedicel glucoside (extracted from jiubing, purity > 98%).

[0019] 1.2 Control drug: ribavirin, oleanolic acid, extract of the medicinal material of Qubing (see Example 1)

[0020] 1.3 Virus strain: Influenza A H1N1 influenza virus murine lung adaptation strain (FM / 1 / 47 strain). Passage chicken embryos, test in BSL-3 (Biosafety Laboratory Level 3), subpackage, and store at -80°C.

[0021] 1.4 Cell model: dog kidney cell MDCK cell

[0022] The above drugs were fully dissolved in dimethyl sulfoxide (DMSO) and stored at -20°C for later use.

[0023] 2. Experimental method

[0024] 2.1 Determination of virus virulence

[0025] 100 μl of 10-concentration virus solutions obtained by 10-fold serial dilution were set up in 8 replicate wells for each concentration, and were sequentially inoculated into a 96-well plate covered with a single layer of MDCK cel...

Embodiment 3

[0034] Example 3 In vivo Influenza Suppression Experiment

[0035] 1. Experimental materials

[0036] 1.1 Tested drug: pedicel glucoside (extracted from jiubing, purity > 98%).

[0037] 1.2 Control drug: Tamiflu, oleanolic acid, extract of the medicinal material of Qubing (Example 1)

[0038] 1.3 Virus: Mouse lung-adapted strain of influenza A H1N1 virus (FM / 1 / 47 strain). Passage chicken embryos, test in BSL-3 (Biosafety Laboratory Level 3), subpackage, and store at -80°C.

[0039] 2. Experimental animals

[0040] 80 BALB / c mice weighing 18g-22g were purchased from Guangdong Experimental Animal Center.

[0041] 3. Experimental method

[0042] The BALB / c mice were randomly divided into 8 groups, namely, the blank control group, the model control group, the Tamiflu control group, the oleanolic acid group, the medicinal material extract group of Jubiying, and the high, medium and low levels of pedicel glucoside. 3 dosage groups, 10 rats in each group. Except for the blank ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An application of pedunculoside in preparation of anti-influenza medicines is disclosed for the first time by the invention, and an application of the pedunculoside in preparation of medicines treating pneumonia caused by influenza viruses is further disclosed. In-vitro cell experiments prove that the IC50 value of the pedunculoside for inhibiting H1N1 influenza viruses is 7.6 [mu]g / mL, and is equivalent to that of ribavirin that is a positive drug. Mouse influenza model pharmacological experiments prove that the pedunculoside can significantly reduce the lung index of mice infected with influenza viruses, and has a certain dose-effect characteristic for H1N1, thus indicating that the compound can control influenza viruses, and can be adopted as an active component to prepare anti-influenza medicines.

Description

technical field [0001] The invention relates to a new pharmaceutical application of pedicel glucoside, in particular to the application of pedicel catechin in the preparation of anti-influenza virus drugs. Background technique [0002] Influenza virus (abbreviated as influenza virus) is a RNA virus that causes influenza in humans, pigs, poultry and other animals. Among them, influenza A virus is easy to mutate due to its antigenicity, and the influenza A H1N1 influenza caused by it has the characteristics of wide epidemic range, strong infectivity, and high incidence rate. At present, antiviral drugs clinically used to prevent and treat influenza virus mainly include M2 ​​ion channel inhibitors amantadine, including amantadine and rimantadine; and neuraminidase inhibitors, including oseltamivir and Zanamivir. Although they can effectively control the disease, the long-term use of these two types of drugs is prone to cause virus mutation, drug resistance and various side ef...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7024A61P31/16A61P11/00
CPCA61K31/7024
Inventor 王永刚姚宏亮张伟建彭维李沛波苏薇薇
Owner SUN YAT SEN UNIV